GPCR

Structure Therapeutics Inc. - American Depositary Shares (GPCR)

About Structure Therapeutics Inc. - American Depositary Shares (GPCR)

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in February 2019 and is headquartered in South San Francisco, CA.

Details

Daily high

$23.98

Daily low

$22.79

Price at open

$23.21

52 Week High

$62.74

52 Week Low

$13.22

Market cap

1.3B

Dividend yield

0.00%

Volume

415,536

Avg. volume

1.3M

P/E ratio

-10.06

Structure Therapeutics Inc. - American Depositary Shares News